Cellectis S.A.

CLLS Stock Healthcare Biotechnology
$3.40
-0.16 (-4.36%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+19.3%
3 Months
-3.4%
YTD
-29.8%
1 Year
+27.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
75.4%
Largest decline max drawdown, since Aug 2025
-51.4%
Risk-adjusted return Sharpe ratio, 1-year
0.69

Own CLLS?

See how CLLS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.